• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • LACOSAMIDE TEVA
    / Abic


    Active Ingredient
    Lacosamide 50, 100, 150, 200 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    14× 50mg

    partial basket chart

    Film Coated Tablets

    56×100mg/150mg/200mg

    partial basket chart

    Dosage

    Lacosamide dosage adjusted for different age groups and weights.
    Adolescents and children weighing 50 kg or more and adults
    Lacosamide as monotherapy: The usual initiation dose is 50,100 mg twice a day, the  dose may be increased every week by 50 mg (administered twice daily)  until you reach a maintenance dose between 100 mg and 300 mg twice a day.
    Lacosamide in combination with other antiepileptic medicines:
    The usual initiation dose of Lacosamide is 50 mg twice a day.
    The dose  may be increased every week by 50 mg(administered twice daily)  until you reach a maintenance dose between 100 mg and 200 mg twice a day.
    Patients ≥50 kg
    Lacosamide treatment with a single loading dose of 200 mg.
    Starting ongoing maintenance dose 12 hours later.
    Children and adolescent weighing <50 kg
    The dose depends on the body weight.
    Manner of use: If necessary, the tablet may be crushed and immediately swallowed.
    The medicine may be taken with or without a meal.


    Indications

    Indicated as monotherapy and adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in patients with epilepsy aged 4 years and older.


    Contra-Indications

    Hypersensitivity to the active substance or any of its excipients.
    Patients with 2nd or 3rd AV block.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE